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and §Department of Chemistry, University of Alberta, Edmonton, Alberta, CanadaABSTRACT Interactions of monomeric alpha-synuclein (aS) with lipid membranes have been suggested to play an important
role in initiating aggregation of aS. We have systematically analyzed the distribution and self-assembly of monomeric aS on
supported lipid bilayers. We observe that at protein/lipid ratios higher than 1:10, aS forms micrometer-sized clusters, leading
to observable membrane defects and decrease in lateral diffusion of both lipids and proteins. An aS deletion mutant lacking
amino-acid residues 71–82 binds to membranes, but does not observably affect membrane integrity. Although this deletion
mutant cannot form amyloid, significant amyloid formation is observed in the wild-type aS clusters. These results suggest
that the process of amyloid formation, rather than binding of aS on membranes, is crucial in compromising membrane integrity.INTRODUCTIONThe 14.4-kDa neuronal protein aS is a major component of
Lewy bodies, which are a pathological hallmark of Parkin-
son’s disease (1). Neuronal death has been attributed to
various causes (2–6), all of which involve the aggregation
of aS into amyloid structures. Above a critical concentra-
tion, aS aggregates in vitro into oligomers and fibrils (7),
with the details of aggregation depending on pH (8), salt
(9), and temperature (8) conditions. There is increasing
evidence that interactions with lipid bilayers play a role in
aS aggregation (10,11), although there have been some un-
resolved debates in earlier literature (12,13).
Alpha-synuclein-lipid membrane interactions depend on
the negative charge on the membrane (12). These interac-
tions are mediated by positively charged residues located
in seven imperfect repeats in the N-terminus of the protein
(14,15). These repeats are reminiscent of lipid-membrane
binding domains in apolipoproteins, with the first five
repeats predicted and shown to form a-helices upon binding
to negatively charged small unilamellar vesicles (SUVs)
(16,17).
In vitro, the presence of negatively charged lipid
membranes accelerates aS aggregation into amyloids (12).
For other amyloid-forming proteins like Ab and IAPP,
membrane integrity is affected by extensive membrane
remodeling and lipid extraction (18–23). There is increasing
evidence that this is also the case for aS (11,24–27).
Further, the report of measurable amounts of lipids in
Lewy bodies (6) strongly suggests that the interaction of
lipid membranes with aS is relevant in the aggregation
process.
One of the major reasons for neuronal cell death in
Parkinson’s disease is membrane damage (28–30). It is un-Submitted January 31, 2014, and accepted for publication May 1, 2014.
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tion process itself causes the observed membrane damage.
Moreover, the exact mechanism of this damage remains to
be elucidated. Both monomers and oligomers of WT-aS
have been shown to cause dye leakage in model membrane
vesicles, consistent with a pore-like mechanism (31–34).
However, this leakage is observed only at high surface
charge densities indicating that other mechanisms may be
important at physiologically relevant charge densities.
WT-aS oligomers with a putative channel-like structure
have been shown to induce single ion-channel currents in
lipid membranes (35). Recent reports also indicate that addi-
tion of monomeric wild-type aS (WT-aS) causes membrane
damage in supported lipid bilayers (SLBs) (24,26). Thus, it
is unclear whether membrane damage is due to aS amyloid
formation on the membrane or is a result of binding of aS
species to the membrane. To distinguish between these
two mechanisms for membrane damage, we studied a
deletion mutant lacking amino-acid residues 71–82 (aS
(D71–82)) that in solution fails to form amyloids but forms
spherical oligomers with a diameter of ~20 nm (36).
We used SLBs as a platform to visualize and measure the
interactions of WT-aS and aS(D71–82) with membranes by
confocal microscopy using fluorescently labeled SLBs and
aS. We indirectly modulated the rate of aggregation of aS
on the membrane surface by varying the negative lipid
composition and thereby modulating the density of
surface-bound protein. The presence of a charged protein
on a charged membrane surface can influence lateral lipid
diffusion and protein-protein interactions. We used fluores-
cence recovery after photobleaching (FRAP) to measure
changes in the lateral diffusion coefficients of lipids to
extract quantitative information about lipid phase and
fluidity. FRAP was also used to probe diffusion of aS
and its aggregation on the SLB surface. We observe that for-
mation of amyloids by WT-aS results in lipid extraction andhttp://dx.doi.org/10.1016/j.bpj.2014.05.001
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observed with the deletion mutant even though it binds
membranes with comparable affinity.MATERIALS AND METHODS
Stock solutions of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line), POPG (1-palmitoyl,2-oleoyl phosphatidylglycerol), and NBD-PC
(1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-
glycero-3-phosphocholine) in chloroform were purchased from Avanti
Polar Lipids (Birmingham, AL) and used without further purification.
EDTA (ethylenediaminetetraacetic acid) was purchased from Sigma Chem-
ical (St. Louis, MO). NaCl (sodium chloride), NaOH (sodium hydroxide),
and HEPES (4-(2-hydroxyethyl)-1-piperazineethanessulfonic acid) were
purchased from Merck (Darmstadt, Germany). Alexa Fluor 647 C2
maleimide and b-BODIPY FL C5-HPC (2-(4,4-difluoro-5,7-dimethyl-4-
bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-
phosphocholine) was purchased from Invitrogen (Carlsbad, CA).Substrate pretreatment
Glass coverslips were washed in 2% Hellmanex (VWR International,
Chicago, IL) at 80C for 60 min, rinsed exhaustively with deionized water,
and then dried with a stream of nitrogen. The slides were etched for 8 min in
a solution of 3:1 (v/v) concentrated sulfuric acid (H2SO4) and 30%
hydrogen peroxide (H2O2). The slides were stored in Milli-Q water
(Millipore, Billerica, MA), and were used within 3 days after treatment.Vesicle and supported lipid bilayer preparation
Lipid stock solutions of POPC and POPG in chloroform were mixed in 1:1
or 3:1 molar ratios, dried under a stream of nitrogen, and placed under
vacuum for 1 h. After drying, the lipid films were rehydrated in 100 mM
NaCl solution. Large unilamellar vesicles (~500 mM in lipids) were pre-
pared by extruding the solution 21 times through 100 nm polycarbonate
membranes. The vesicles were stored at 4C and used within 3 days. Sup-
ported lipid bilayers were formed by vesicle fusion inside a 120 mL custom-
built chamber on appropriately treated glass slides. The extruded vesicles
were mixed with 750 mM NaCl solution at a 1:1 ratio to induce fusion as
reported in Pandey et al. (37). After 20 min incubation, excess vesicles
were removed from the chamber by rinsing with a 50 mM HEPES,
0.1 mM EDTA, and 750 mM NaCl, pH 7.4 buffer. Thereafter the chamber
was rinsed with 50 mM HEPES, 0.1 mM EDTA, pH 7.4 buffer to remove
salt. At least 3 mL of buffer were passed through the chamber to ensure
complete solvent exchange.Expression, purification, and labeling of aS
Because WT-aS does not contain any cysteine residues necessary for fluo-
rescent labeling, an alanine to cysteine mutation was introduced at residue
140. The WT-aS-A140C mutant was expressed in Escherichia coli strain
BL21 (DE3) using the pT7-7 expression plasmid and purified in the pres-
ence of 1 mM DTT as previously reported in van Raaij et al. (38). The
cDNAs for the deletion mutant of aS lacking 71–82 residues (aS
(D71–82)) were obtained from Prof. Benoit Giasson from the University
of Florida (Gainesville, FL). The cDNAwas cloned into a pT7-7 expression
plasmid and purified. For labeling aS(D71–82), an alanine to cysteine
mutation was introduced at residue 140 as for the WT-aS. Before labeling,
both WT-aS-A140C and aS(D71–82)-A140C were reduced with a fivefold
molar excess of DTT for 30 min at room temperature. The samples were
desalted with Zeba desalting columns (Pierce, Rockford, IL), followed by
the addition of a twofold molar excess of Alexa 647 (AL647) C2 maleimideBiophysical Journal 106(12) 2585–2594dye (Invitrogen) and incubated for 2 h in the dark at room temperature. Free
label was removed using two desalting steps. The protein labeling effi-
ciency was estimated to be 90% from the absorption spectrum. Before
use, the protein was diluted with 50 mM HEPES, 0.1 mM EDTA, pH 7.4
buffer to the desired concentrations.Imaging of supported lipid bilayers and proteins
All measurements were performed on a model A1 confocal microscope
equipped with a perfect focus system (Nikon, Tokyo, Japan). SLBs were
visualized by incorporating 0.25 mol % BODIPY-PC. To visualize the pro-
teins, a mixture of 25% labeled and 75% unlabeled protein was used. The
SLBs were prepared as reported in Pandey et al. (37). In a typical experi-
ment, exactly two times the chamber volume (~240 mL) of the desired con-
centrations of the protein was flushed into the perfusion chamber with an
oil-free pump. The proteins were incubated with the SLBs for 18 h at
room temperature. Thereafter the unbound protein was washed off with
50 mM HEPES, 0.1 mM EDTA, pH 7.4 for 10 min to remove background
fluorescence from the unbound protein in the solution. Although the
washing step could potentially lead to desorption, within the time frame
of the measurements we see <10% decrease in the protein fluorescence
from these bilayer systems. Images were acquired using a 63 water
immersion, 1.30 NA objective combined with a 2 optical zoom. The
acquired images consisted of 512  512 pixels with a pixel size of
0.41  0.41 mm. All images were collected under identical conditions of
power and gain. For visualization purposes only, the contrast threshold
was set to a constant value, allowing comparison of all images.Image processing and cluster analysis
The NIS ELEMENTS ObjectCount module (Nikon) was used for area esti-
mation of aS clusters. Using intensity thresholding, areas of aS clusters
were calculated automatically from the pixel areas in at least 10 images
per protein concentration. Because the number of clusters and their sizes
depend directly on the level of the threshold set, we systematically varied
the threshold (see Fig. S1 in the Supporting Material) to choose an optimum
threshold. For each image, the intensity threshold was fixed to 1.5 times the
peak intensity of its intensity histogram, avoiding under- or over-sampling.
The cluster area distribution for each protein concentration was fit to a log-
normal distribution to get an average cluster area (39).Fluorescence recovery after photobleaching
FRAP was used to determine the diffusivity of lipids in the bilayer and of
the labeled protein on the lipid bilayer after incubation. FRAP was per-
formed on a model A1 confocal microscope (Nikon). A 100-mW Argon
ion laser (488 nm; Coherent, Santa Clara, CA) was used to both bleach
and monitor the lipid bilayer fluorescence. A 30-mW laser (647 nm;
Coherent) was used to bleach and monitor protein fluorescence. In the
FRAP experiment, fluorescence from a circular region of interest (ROI)
was bleached (radius ~12 mm) in 1.5 s. After bleaching, the increase in
fluorescence intensity in the ROI was monitored for 8 min. During the
experiment, there was only a minimal drop in the fluorescence intensity
in the reference ROI. All FRAP data were fitted using the Soumpasis fit
(40), which has been shown to better model membrane/protein diffusivity
than a single exponential fit (41), yielding the diffusion coefficients and
mobile fractions of the probed entity.Circular dichroism spectroscopy
A model J-715 spectropolarimeter (Jasco, Tokyo, Japan) was used to obtain
circular dichroism (CD) spectra at protein concentrations of 3 mM in solu-
tion. Spectra were recorded between 190 and 260 nm with a step size of
FIGURE 1 Binding of WT-aS and aS(D71–82)with POPC/POPG lipo-
somes. Titration of WT-aS (red squares) and aS(D71–82) (blue circles)
by POPC/POPG (50:50) SUVs. The bound fractions were obtained by
measuring mean residual ellipticities at 222 nm by CD spectroscopy
(Materials and Methods). The binding curve was generated by fitting
normalized ellipticity values to Eq. 2 (solid lines), assuming equivalent
binding sites. The error bars indicate standard deviations from three inde-
pendent measurements. To see this figure in color, go online.
a-Synuclein Amyloids Damage Membranes 25870.5 nm and a scanning speed of 10 nm/min using a 1-mm path length
cuvette. The apparent dissociation constants (Kdapp) for both proteins
were determined by titrating them against POPC/POPG (50:50) SUVs
and fitting the measured mean residue ellipticity at 222 nm, R, to the solu-
tion of the binding equilibrium equation:
Pþ L
n
4R: (1)
By assuming equilibrium binding and applying the law of mass action, solv-
ing for R, we obtain
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where R is the measured signal (MRE (Mean Residual Ellipticity) at
222 nm, corrected for dilution) at a given lipid concentration, L is the total
lipid concentration, and P is the total concentration of the protein. Kdapp is
the apparent macroscopic dissociation equilibrium constant, and n is the
binding stoichiometry (lipids/protein). The values Rf and Ro are the final
(corrected for dilution) and initial mean residue ellipticities, respectively.
This equation assumes that all lipid-binding sites are equivalent and that
Kdapp does not depend on the lipid/protein ratio (L/P) (42). Because aS
adopts a helical conformation upon membrane binding (16), titration of
WT-aS and aS(D71–82) with POPC/POPG (1:1) SUVs allows an estimate
of Kdapp from the characteristic band at 222 nm.FIGURE 2 Clustering of WT-aS and aS(D71–82) on POPC/POPG
supported lipid bilayers. Representative images of SLBs after adsorption
of 10 mM aS for 18 h. The protein images show bigger and more heteroge-
neous WT-aS protein aggregates on 50% POPG-containing bilayers asRESULTS
WT-aS and aS(D71–82) bind lipid membranes
with comparable affinities
To compare the clustering and possible aggregation of WT-
aS and aS(D71–82) on lipid membranes, the binding of
both proteins to SLBs has to be comparable. We used CD
spectroscopy to measure binding affinities of aS(D71–82)
and WT-aS to POPC/POPG (1:1) SUVs (42) (Materials
and Methods). The data (Fig. 1) show that the binding affin-
ities of both constructs to the lipid bilayer are comparable.
Although the WT-aS and aS(D71–82) exhibit similar
binding affinities to lipid membranes, they show different
aggregation behavior in solution. In absence of membranes,
aS(D71–82) does not form fibrillar amyloids (36) and
aggregation arrests at an oligomeric stage (43), whereas
WT-aS readily aggregates into cross-b-sheet-rich amyloid
structures. Aggregation experiments under our experimental
conditions confirmed this reported difference in aggregation
behavior (see Fig. S2).compared to those of aS(D71–82) mutant. There appears to be little corre-
lation between the defects on the SLBs and the bigger aggregates. The lipid
images show the appearance of cracks and defects in the top panels (WT-
aS). (Inset) Enhanced magnification. The sparse lipid clustering (seen as
bright spots) was also seen in the controls and aS(D71–82) aggregates do
not seem to have a preference for these regions. Fewer and smaller defects
appear in the presence of aS(D71–82) and the average intensity remains the
same. Images are contrasted to the same extent to facilitate comparison. All
experiments were performed at room temperature in 50 mM HEPES,
pH 7.4, 0.1 mM EDTA buffer. The scale bar is 10 mm.WT-aS and aS(D71–82) self-assemble differently
on POPC/POPG (1:1) SLBs
Upon systematically varying the concentration of aS on
POPC/POPG (1:1) SLBs, we observed that both WT-aS
and aS(D71–82) organized into clusters on the SLB surface.
Although the binding affinities of these proteins were com-parable, there was a clear difference in the organization of
these clusters (Fig. 2), obtained upon incubation of 10 mM
protein on SLBs after 18 h (P/L ratio ~1:1).
WT-aS assembles into a heterogeneous distribution of
clusters of both small and large areas, whereas clusters of
aS(D71–82) are more homogenous in size. Upon decreasing
the P/L ratio, we observe that assembly of both WT-aS (seeBiophysical Journal 106(12) 2585–2594
2588 Iyer et al.Fig. S3) and aS(D71–82) clusters (see Fig. S4) are sensitive
to protein concentration, with cluster size increasing as a
function of protein concentration. To obtain a quantitative
overview of protein cluster size, we estimated average
cluster areas (Materials and Methods) by fitting the
measured area distribution to a log-normal distribution.
Fig. 3 depicts the correlation between the protein concentra-
tion and average cluster areas.
As shown in Fig. 3, we obtained aS cluster areas from
incubation of WT-aS and aS(D71–82) on POPC/POPG
(75:25) SLBs (see Fig. S5). This experiment was done to
investigate whether the percentage of negatively-charged
lipids influenced the clustering of aS on SLBs. The WT-aS
clusters are consistently smaller on less negatively charged
SLBs (i.e., 25 vs. 50% POPG content). The histograms of
the cluster areas (see Fig. S6) show a more heterogeneous
distribution (larger widths) for the WT-aS clusters at all
concentrations. The smallest calculated cluster area using
our thresholding parameters is 0.04 mm2, which corresponds
to the pixel area in the image. We cannot make any conclu-
sive predictions about the size or aggregation number (num-
ber of monomers) of aS structures inducing membrane
damage. At these high P/L ratios (1:1), it has been previously
reported that WT-aS forms amyloid structures depending on
the percentage of negative charge in the lipid membranes
(12). Our observations show a charge-dependent increase
in the size of WT-clusters on SLBs at high P/Ls.
To establish whether the observed WT-aS clusters
contain amyloid, SLBs containing 10 mM WT-aS clusters
were incubated with 50 mM of ThT (ThioflavinT) for 1 h.
After washing off unbound ThT, most of the clusters seenFIGURE 3 Average cluster areas of aS on SLBs with changing protein
concentration and lipid composition. Average cluster areas obtained by
fitting the area distributions obtained from aS aggregates on POPC/
POPG SLBs. Upon increasing protein concentration, there is a twofold in-
crease in the average cluster areas irrespective of the lipid composition for
both WT-aS and aS(D71–82). However, for a given protein concentration,
aS(D71–82) clusters (red symbols) show little dependence on lipid compo-
sition contrary to that observed for the WT-aS clusters (black symbols).
Cluster areas for WT-aS and aS(D71–82) on 50% POPG SLBs (squares)
and 25% POPG SLBs (triangles). The error bars indicate standard errors
in each case. The statistics underlying the values presented here are shown
in Table S1 in the Supporting Material. To see this figure in color, go online.
Biophysical Journal 106(12) 2585–2594in the protein channel were found to be positive for ThT
fluorescence (Fig. 4), confirming the formation of amyloid
aggregates on the SLB surface (18,24). The average inten-
sities in all ThT-positive clusters were at least 150 times
higher than background intensities. It is interesting to note
that not all clusters of WT-aS are positive for ThT fluores-
cence (Fig. 4 B).
To investigate whether the clusters of WT-aS can reorga-
nize and grow into bigger amyloid aggregates, we incubated
the aggregates formed from 10 mM WT-aS after 18 h on
POPC/POPG (1:1) SLBs for another 24 h. As expected
for amyloid growth, we observe a marked increase in the
protein aggregate size, as shown in Fig. 5. Closer inspection
of theWT-aS amyloid aggregates in Fig. 5 show evidence of
lipid fluorescence (arrows in Fig. 5). This may be a result of
lipids being extracted out of the membrane upon amyloid
formation. We see fewer protein aggregates at this stage,
which suggests that smaller aggregates fuse into bigger
structures; however, an alternative explanation could be
that the aggregates desorb from the membrane.Aggregation of aS affects lipid membrane
mobility
Protein aggregation on SLBs requires that the observed
clusters are mobile on the bilayer. This mobility would be
affected by the protein-protein interactions required for
aggregation into amyloid fibrils. The dependence of protein
clustering on lipid composition further suggests that thereFIGURE 4 ThioflavinT (ThT) staining of WT-aS aggregates. Represen-
tative fluorescence images depicting the lipid channel (A) and protein chan-
nel (B) after 18 h incubation of 10 mM labeled WT-aS on POPC/POPG
SLB. (White arrows) Aggregates of WT-aS which are not positive for
ThT. (C) Fluorescence images taken after ThT staining. (D) Overlay of
all channels. Lipid composition of the bilayer was POPC/POPG/
BODIPY-PC, 50:49.75:0.25 (mol/mol). All images were taken at room
temperature in 50 mM HEPES, 0.1 mM EDTA, pH 7.4 buffer. The scale
bar is 10 mm. To see this figure in color, go online.
FIGURE 5 Time-dependent growth of WT-aS aggregates on POPC/
POPG (50:50) SLBs. The images shown are representative endpoint images
obtained after incubation of 10 mM WT-aS on POPC/POPG (50:50) after
18 h (top panel) and the same bilayer incubated for another 24 h (bottom
panel). Upon incubation for 18 h, large aggregates are seen on the bilayer
surface but these aggregates do not coincide with regions of high membrane
damage. After 42 h, very large aggregates appear that in some regions
appear to incorporate lipids. (Solid arrows) Lipids lining along the shape
of the aggregate suggesting incorporation. Images are contrasted to the
same extent to facilitate proper comparison. All experiments were per-
formed at room temperature in 50 mM HEPES, pH 7.4, 0.1 mM EDTA
buffer. The scale bar is 10 mm. To see this figure in color, go online.
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aggregation state of aS, we used FRAP to probe the diffu-
sion of WT-aS and aS(D71–82) on SLBs. We observed
that at 10 mM protein concentration the diffusion coefficient
of WT-aS (DaS) had a much lower value (~0.14 mm
2/s) than
that for aS(D71–82) (~1.1 mm2/s) (Fig. 6 A). The aS
(D71–82) mutant diffuses much faster than the WT-aS at
all protein concentrations. We attribute the faster diffusion
to significantly reduced interactions between aS(D71–82)
species as compared to that of WT-aS. Consistent with
strong protein-protein interactions and amyloid formation
we observed a decrease (up to 30%) in the mobile fraction
of the WT-aS species with increasing concentrations of
the protein (Fig. 6 B).
The mobile fraction of aS(D71–82) does not change. We
analyzed the average fluorescence intensities from the
protein channel after incubation of labeled WT-aS and
aS(D71–82) on POPC/POPG SLBs. SLBs incubated with
different concentrations of WT-aS showed a linear increase
in fluorescence intensity whereas SLBs with aS(D71–82)
did not. Intriguingly, a similar trend was observed with
WT-aS upon decreasing the percentage of negative lipids
in the SLBs (Fig. 6 C). After incubation for 18 h, the un-
bound protein was washed off. Because the binding affin-
ities of WT-aS and aS(D71–82) were comparable, the
SLBs should be fully covered with aS at all concentrations
used. Thus, after the washing step, the fluorescence intensity
should have been comparable for SLBs incubated with WT-
aS and aS(D71–82). The fact that we see an increase influorescence intensity with increasing concentration of
WT-aS suggests direct adsorption of incoming WT-aS
onto attached WT-aS species. A higher intensity could
also be a result of compaction of existing aggregates into
ordered structures, thereby creating space for incoming
monomers.
To investigate the effect of aS binding on lateral mobility
of lipids in POPC/POPG SLBs, we used FRAP with
BODIPY-PC as a fluorescent lipid probe. The diffusion
coefficient of BODIPY-PC in the absence of protein was
found to be ~1.25 mm2/s, similar to values reported in the
literature for lateral diffusion of lipids in SLBs on glass sur-
faces (44,45). The lipids were completely mobile (mobile
fraction >98%) and SLBs were found to be stable over an
incubation period of at least 42 h. Increasing concentrations
of WT-aS (P/L ratios from 0.02 to 1) were incubated on
separate SLBs for 18 h. After 18 h incubation with WT-
aS, a drop in the diffusion coefficient of BODIPY-PC in
SLBs was observed with increasing P/L values. At P/L <
0.1, there is little effect on the lipid bilayer fluidity, but start-
ing from P/L ~ 0.1, we observe a drop in the diffusion coef-
ficient of BODIPY-PC (DB) (Fig. 6 D). The mobile fraction
of BODIPY-PC remained unchanged upon incubation of
WT-aS and aS(D71–82) at all protein concentrations and
lipid compositions. DB dropped by ~55% and ~30% on
50% POPG and 25% POPG SLBs, respectively. Upon incu-
bation of similar concentrations of aS(D71–82) on POPC/
POPG SLBs, we found no change in the apparent diffusion
coefficients of BODIPY-PC in either lipid composition as
seen in Fig. 6 D. The increase in the protein aggregate
size coincides with the drop in DB. Thus, formation of small
protein clusters is not enough to decrease the lateral diffu-
sion of lipids, whereas aggregation of aS into larger clusters
and/or amyloids with typical cross-b sheets is correlated
with the decreased lateral diffusion of SLBs.Amyloid formation and lipid extraction are
correlated
To probe the effects of WT-aS aggregation and aS(D71–82)
clustering on the integrity of SLBs, we systematically
varied the concentration of aS on SLBs. BODIPY-PC at
0.25 mol % was incorporated to visualize the SLBs. In the
absence of protein, the bilayers were devoid of defects,
cracks, or any other inhomogeneities resolvable by our
confocal microscope (Fig. 2; Control). Upon adding
increasing concentrations of WT-aS to separate SLBs, we
observe a general loss of BODIPY-PC fluorescence intensity
and appearance of defects with no lipid present (black
regions in images) and patterns of elongated cracks with
lower-than-average fluorescence intensities, suggesting
damage to the SLBs (Fig. 2) after 18 h.
We observed that the extent of this damage seems to
reduce as the protein concentration is reduced (P/L from 1
to 0.02) (see Fig. S3). In contrast to what was observedBiophysical Journal 106(12) 2585–2594
FIGURE 6 Effects of adsorption of aS on lipid
and protein dynamics of the SLBs. In all the
figures, measurements with WT-aS are shown
(black symbols), and those with aS(D71–82)
(red symbols); measurements on 50% POPG-
containing membranes (square symbols) and those
on 25% POPG-containing membranes (triangular
symbols). (A) Apparent protein diffusion co-
efficients (DaS). (B) Mobile fractions in protein
channel obtained from FRAP upon incubation of
aS WT-aS and aS(D71–82) on POPC/POPG
SLBs in increasing concentrations. (C) Average
intensities (normalized to background of red
channel) obtained from protein channels after
18 h incubation and removal of unbound protein.
The WT-aS clearly shows a concentration-depen-
dent rise in adsorbed protein irrespective of %
of negative charge on SLBs, whereas aS
(D71–82) intensities do not change with concen-
tration. (D) Protein concentration-dependent
changes in lateral diffusion coefficients of
BODIPY-PC (DB) relative to that in the absence
of protein. The error bars indicate standard devia-
tion obtained from five independent measure-
ments in panels A–C and from 10 independent
measurements in panel D. All experiments were
performed at room temperature in 50 mM
HEPES, pH 7.4, 0.1 mM EDTA buffer. Note:
the protein diffusion measurements (B and C) at 200 nM had poor signal/background and therefore much poorer fits to the recovery curves and greater
variability in both diffusion coefficient and mobile fractions estimates. To see this figure in color, go online.
2590 Iyer et al.with WT-aS, when aS(D71–82) is added to the SLBs, there
was much less evidence of damage to SLBs (see Fig. S4).
However, aS(D71–82) did form smaller clusters on the
bilayer surface, as seen in Fig. 2. Control experiments
involving SLBs incubated in buffer show no such damage
over the timescale of the experiments. Moreover, these
SLBs show negligible loss in BODIPY-PC fluorescence
intensity over a period of at least 42 h. The onset of aggre-
gation of WT-aS to form amyloid structures is faster with
increasing composition of negatively charged lipids (12).
Accordingly, to probe whether amyloid formation was
involved in the observed membrane damage, we decreased
the proportion of negative lipids. Upon incubation of
10 mM protein on POPC/POPG (75:25) SLBs for 18 h, we
found that WT-aS causes fewer and smaller defects,
whereas aS(D71–82) mutants show almost no defect forma-
tion (see Fig. S5).
We measured the lipid fluorescence in the buffer solution
above the SLBs before and after incubation with protein for
18 h. After protein incubation, there is a concentration
dependent increase in lipid fluorescence. This increase is
~3–4-fold larger for WT-aS than for aS(D71–82) (see
Fig. S7). These results suggest that the general loss of lipid
fluorescence after incubation with WT-aS could be due to
lipid extraction. We suggest that formation of amyloid struc-
tures in WT-aS occurs concurrently with extraction of lipids
from the SLBs.
To test whether loss in membrane fluidity, membrane
damage, and aggregate formation are influenced by theBiophysical Journal 106(12) 2585–2594BODIPY probe, SLBs containing a small fraction of
NBD-PC lipids were incubated with 5 mM and 10 mM
WT-aS. Similar defects, cracks in the lipid membrane,
and protein aggregate formation were observed. We
conclude that the specific fluorescent probe does not influ-
ence our observations. We find the same decrease in DB
upon incubation with unlabeled protein (5 mM and 10 mM
WT-aS) rather than 25% labeled and 75% unlabeled pro-
tein, confirming that there is no significant effect on DB
from adding the fluorophores.DISCUSSION
WT-aS and aS(D71–82) behave differently on SLBs.
Collectively, the data presented here shows that the adsorp-
tion of protein to the membrane surface results in protein
clustering. Depending on the interactions between proteins,
this clustering can result in the formation of amyloid, which
causes significant perturbations in the bilayer structure and
dynamics.
As the concentration of WT-aS is increased, the lipid
structure is altered by formation of defects that appear to
be devoid of lipid and by formation of a pattern of cracks
with fewer lipids. Concurrently, the rate of diffusion of the
lipid decreases, suggesting that diffusion is either hindered
by the formation of cracks or slowed down by a strong asso-
ciation of lipid with protein clusters. As the concentration of
aS(D71–82) mutant is increased, there are a few defects but
there is no evidence of other perturbations to the lipid
a-Synuclein Amyloids Damage Membranes 2591membranes. We see no cracks and DB is unaffected. There is
also minimal loss of lipid. The perturbations by the WT-aS
on the SLBs become more severe as the time of incubation is
increased from 18 to 42 h. It is also important to note that
there are no defects or lipid loss in samples without protein
even after 42 h.
The effects of the WT-aS on the membrane fluidity and
integrity are generally lipid-composition-dependent and
more pronounced at high fractions of negatively charged
lipids (POPG). Changing the composition of the lipid does
not change the effects of the aS(D71–82) mutant on these
membrane properties. Both WT-aS and aS(D71–82) are
expected to adsorb on the membrane in comparable amounts
owing to their comparable membrane binding. However, as
the protein concentration is increased the amount of
adsorbed WT-aS increases linearly, whereas there is no
change in the amount of adsorbed aS(D71–82) mutant.
Interestingly, the adsorption of the aS(D71–82) mutant is
lower on membranes with lower proportion of charged
lipids, whereas that of the WT-aS is not. This is consistent
with the additional adsorption of the WT-aS arising from
protein-protein binding rather than protein-lipid binding.
Both the WT-aS and aS(D71–82) mutant appear to form
small clusters of protein on the surface. As the concentration
increases, the average area of these clusters increase by
approximately a factor of two. At all concentrations, the
average cluster area of the WT-aS is larger on the highly
charged membranes. This agrees with the earlier observa-
tions that at high protein/lipids, a high percentage of nega-
tive lipids increases the rate of aggregation of WT-aS
(12). Moreover, WT-aS is seen to form very large clusters
of protein at high concentrations and longer incubation
times. These large clusters are stained positively by ThT,
supporting the conclusion that the proteins in the clusters
tend to aggregate into amyloid fibrils. Such large ThT
positive structures are not observed for the deletion mutant.
The largest amount of membrane damage occurs when
amyloid structures form.
Therefore, the most likely explanation for the observed
membrane damage would be the aggregation of WT-aS
into amyloids characterized by a significant cross-b
sheet component on the membrane surface. The evidence
for the extent of membrane damage is indirect, but support
the conclusion that both lipid leaflets are removed because
the fluorescence in these regions is reduced to background
levels. In the cracks, the fluorescence is reduced, but not
to the background levels, so these perturbations may be
limited to the top leaflet. Defects in the SLBs are seen
starting from P/L ratios of 1:10 and increase in frequency
with higher concentrations. Vesicle permeabilization assays
showed hardly any dye efflux with POPC/POPG large uni-
lamellar vesicles (34), motivating us to test an alternative
mechanism. Our data are consistent with a mechanism of
membrane damage including lipid extraction and incorpora-
tion in amyloid structures.Prior reports also suggest that aS mutants having higher
aggregation propensity cause significantly greater mem-
brane damage in SLBs (24) or increased cell death of dopa-
minergic neurons in a rat model (46). Thus, aggregation into
amyloids is likely to be the prerequisite for membrane dam-
age. Previous studies on interaction of WT-aS with POPC/
POPS (1:1) (17) and POPC/POPA (1:1) (12) supported lipid
bilayers using atomic force microscopy also reveal defects
and membrane disruption with formation of protein aggre-
gates on the bilayer surface. Recent studies with model
vesicles suggest a membrane thinning mechanism (47).
WT-aS has previously been shown to cause phase separa-
tion and protein clustering to eggPG-rich domains (37,48)
in eggPC/eggPG (50:50) SLBs. In our experiments, we do
not observe phase separation upon addition of WT-aS;
this may be attributed to the choice of lipids. Aggregate
sizes similar to those observed for aS have also been
observed for b-amyloid (1–40) on POPC/POPG SLBs (49).
The rate of diffusion of the WT-aS is lower than that of
the aS(D71–82) mutant at all concentrations and for both
lipid compositions. Whereas the WT-aS diffusion decreases
at higher concentrations, that of the aS(D71–82) mutant
does not. Correspondingly, the fraction of mobile WT-aS
decreases at high concentrations whereas the aS(D71–82)
mutant remains fully mobile. The decrease in mobile frac-
tion of WT-aS is consistent with the formation of large
amyloid aggregates and to the change in the lipid diffusion,
suggesting a correlation between the two effects.
The diffusivity of the WT-aS is independent of the lipid
composition of the SLBs. However, the aS(D71–82) mutant
moves significantly faster on the less charged membrane.
This may be related to the observation that there is less
protein adsorbed, which would suggest that the protein
diffusion is sensitive to protein concentration on the surface.
Because there appears to be no difference in the average
cluster area for the aS(D71–82) mutant on two differently
charged membranes, the difference in protein diffusion is
not related to the cluster sizes.
If the changes in lipid and protein diffusion are linked, it
could arise from direct protein-lipid bilayer interactions.
This notion is supported by the observation that the large
aggregates colocalize with lipids. The diffusion of the lipid
DB is therefore retarded by the diffusion of the protein DaS
in proportion to the amount bound to the protein as
DB ¼ faDaS þ ð1 faÞDf ; (3)
where Df is the measured diffusion coefficient of BODIPY-
PC in absence of any protein and fa is the fraction of lipid
bound. This relation assumes a rapid exchange between
free and bound lipid on the timescale of the recovery of fluo-
rescence (minutes). Table 1 shows the calculated fractions
(fa) as a function of protein concentration. The value fa in-
creases with protein concentration and with the fraction of
negatively-charged lipids in the SLBs in a self-consistentBiophysical Journal 106(12) 2585–2594
TABLE 1 Cluster-associated fractions of BODIPY-PC on
POPC/POPG SLB
Protein
concentration
(mM)
Measured
DB (mm
2/s)
Measured
DaS (mm
2/s)
fa
(from model)
WT-aS on
POPC/POPG
(50:50) SLBs
10 0.755 0.07 0.155 0.02 0.395 0.06
5 0.815 0.06 0.365 0.09 0.425 0.06
2.5 0.875 0.09 0.375 0.07 0.335 0.07
1.25 1.085 0.05 0.495 0.10 0.115 0.04
0.20 1.145 0.03 0.485 0.07 0.055 0.03
WT-aS on
POPC/POPG
(75:25) SLBs
10 0.845 0.04 0.125 0.01 0.315 0.02
5 1.045 0.06 0.255 0.07 0.185 0.03
2.5 1.105 0.10 0.295 0.05 0.125 0.04
1.25 1.085 0.09 0.355 0.05 0.095 0.04
0.20 0.975 0.06 0.575 0.15 0.145 0.11
aS(D71–82) on
POPC/POPG
(50:50) SLBs
10 1.055 0.04 0.625 0.08 0.055 0.03
5 1.025 0.04 0.565 0.11 0.065 0.02
2.5 1.135 0.09 0.605 0.05 0.045 0.01
1.25 1.045 0.05 0.635 0.15 0.045 0.02
0.20 1.025 0.07 0.845 0.47 0.105 0.05
aS(D71–82) on
POPC/POPG
(75:25) SLBs
10 1.215 0.06 1.165 0.08 0.085 0.03
5 1.215 0.07 1.165 0.10 0.085 0.05
2.5 1.495 0.02 1.025 0.12 0.045 0.01
1.25 1.425 0.05 0.985 0.16 0.035 0.02
0.20 1.095 0.08 0.785 0.17 0.065 0.04
Clusters associated with fraction fa obtained from Eq. 3. This fraction in-
creases with the protein concentration and fraction of negative lipids.
Note: the protein diffusion measurements at 200 nM had poor signal/back-
ground and therefore much poorer fits to the recovery curves and greater
variability in both diffusion coefficients (DaS) and mobile fractions esti-
mates. The error bars indicate standard deviations from five independent
measurements.
2592 Iyer et al.manner. Although BODIPY-PC exhibits reduced lateral
mobility upon incubation with WT-aS, its mobile fraction
remains close to unity at all protein concentrations used.
This suggests that BODIPY-PC is not immobilized beneath
or around the clusters. Thus, the lipids in the SLBs must be
able to exchange within the timescale of the measurement of
fluorescence recovery.A model for aggregation of aS on SLBs
Our operating model for the action of aS on SLBs is illus-
trated in Fig. 7. Alpha-synuclein initially binds the charged
lipids in the membranes via a conformational change that in-
volves the formation of amphipathic a-helical structures.Biophysical Journal 106(12) 2585–2594These adsorbed proteins interact to form small clusters
that are the end points for the self-assembly of the
aS(D71–82) mutant. However, in the WT-aS, clustering is
followed by aggregation allowing additional adsorption of
the protein, and leading to amyloid-containing protein
aggregates. These aggregates bind strongly to negatively-
charged lipids (POPG), thereby reducing the effective
mobility of the lipid mixture. The clusters weakly associate
with POPC because the mobile fraction of BODIPY-PC is
unchanged. If the protein aggregate detaches from the mem-
brane, it would lead to lipid loss.CONCLUSIONS
We report that aggregation of WT-aS on lipid membranes
leads to formation of amyloid structures that grow in time.
This conversion of monomeric WT-aS to amyloid structures
composed of lipids and WT-aS is accompanied by signifi-
cant membrane damage, lipid extraction, and reduced lateral
mobility of lipids in SLBs. This happens more prominently
at high protein to lipid ratios. The aS(D71–82) mutant fails
to form amyloids on the bilayer surface and thus is not able
to damage lipid membranes. Overall, our data suggests
that aggregation of WT-aS on lipid membranes affects
membrane integrity. Whether the membrane damage
observed in our experiments arises from a distinct amyloid
species or the process of amyloid formation remains to be
established.SUPPORTING MATERIAL
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